Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation (Q43714811)

26 November 2017

Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation (English)

1 reference

26 November 2017

ventricular dysfunction

1 reference

J M Pearl

1

1 reference

26 November 2017

D P Nelson

2

1 reference

26 November 2017

C J Wagner

3

1 reference

26 November 2017

J P Lombardi

4

1 reference

26 November 2017

J Y Duffy

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

The Annals of Thoracic Surgery

26 November 2017

1 reference

26 November 2017

72

1 reference

26 November 2017

2

1 reference

26 November 2017

565-570

1 reference

Ultrastructural damage associated with reoxygenation of the anoxic myocardium

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Acute hypoxia and reoxygenation impairs exhaled nitric oxide release and pulmonary mechanics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Circulating endothelin-1 concentrations in patients with chronic hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Endothelin-induced activation of neutrophil migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Relationships between the endothelin and nitric oxide pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Studies of hypoxemic/reoxygenation injury: without aortic clamping. VI. Counteraction of oxidant damage by exogenous antioxidants: N-(2-mercaptopropionyl)-glycine and catalase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Role of nitric oxide in hypoxia-induced changes in newborn rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Endothelin antagonism with bosentan: a review of potential applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hypoxia in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902782-5

10.1016/S0003-4975(01)02782-5

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference